DK155078C - Fremgangsmaade til fremstilling af en administrationsform med reguleret frigoerelse af en biologisk aktiv forbindelse - Google Patents

Fremgangsmaade til fremstilling af en administrationsform med reguleret frigoerelse af en biologisk aktiv forbindelse

Info

Publication number
DK155078C
DK155078C DK004481A DK4481A DK155078C DK 155078 C DK155078 C DK 155078C DK 004481 A DK004481 A DK 004481A DK 4481 A DK4481 A DK 4481A DK 155078 C DK155078 C DK 155078C
Authority
DK
Denmark
Prior art keywords
preparing
procedure
active connection
biological active
regulated release
Prior art date
Application number
DK004481A
Other languages
Danish (da)
English (en)
Other versions
DK4481A (da
DK155078B (da
Inventor
Kenneth L Berger
Jon M Brake
Fred H Deindoerfer
Charles S Bankert
Original Assignee
American Hospital Supply Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Hospital Supply Corp filed Critical American Hospital Supply Corp
Publication of DK4481A publication Critical patent/DK4481A/da
Publication of DK155078B publication Critical patent/DK155078B/da
Application granted granted Critical
Publication of DK155078C publication Critical patent/DK155078C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00Preparation of cellulose ethers
    • C08B11/02Alkyl or cycloalkyl ethers
    • C08B11/04Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals
    • C08B11/14Alkyl or cycloalkyl ethers with substituted hydrocarbon radicals with nitrogen-containing groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B15/00Preparation of other cellulose derivatives or modified cellulose, e.g. complexes
    • C08B15/05Derivatives containing elements other than carbon, hydrogen, oxygen, halogens or sulfur
    • C08B15/06Derivatives containing elements other than carbon, hydrogen, oxygen, halogens or sulfur containing nitrogen, e.g. carbamates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK004481A 1979-05-10 1981-01-07 Fremgangsmaade til fremstilling af en administrationsform med reguleret frigoerelse af en biologisk aktiv forbindelse DK155078C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US3798179A 1979-05-10 1979-05-10
US3798179 1979-05-10
US8000527 1980-05-08
PCT/US1980/000527 WO1980002374A1 (en) 1979-05-10 1980-05-08 Hydroxyalkyl starch drug carrier

Publications (3)

Publication Number Publication Date
DK4481A DK4481A (da) 1981-01-07
DK155078B DK155078B (da) 1989-02-06
DK155078C true DK155078C (da) 1989-07-10

Family

ID=21897414

Family Applications (1)

Application Number Title Priority Date Filing Date
DK004481A DK155078C (da) 1979-05-10 1981-01-07 Fremgangsmaade til fremstilling af en administrationsform med reguleret frigoerelse af en biologisk aktiv forbindelse

Country Status (10)

Country Link
EP (2) EP0019403B1 (zh)
JP (1) JPH0140812B2 (zh)
KR (1) KR840001798B1 (zh)
AT (1) ATE12892T1 (zh)
CA (1) CA1158159A (zh)
DE (1) DE3070546D1 (zh)
DK (1) DK155078C (zh)
ES (1) ES8105145A1 (zh)
NZ (1) NZ193618A (zh)
WO (1) WO1980002374A1 (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3045135A1 (de) * 1980-11-29 1982-06-09 Sandoz-Patent-GmbH, 7850 Lörrach Pharmazeutische kompositionen enthaltende bioabbaubare polymere
DE3421954C1 (de) * 1984-06-13 1985-10-24 Pfrimmer & Co Pharmazeutische Werke Erlangen Gmbh, 8520 Erlangen Diätetisches Nährmittel, enthaltend Hydroxyethylstärke
DK110188D0 (da) * 1988-03-02 1988-03-02 Claus Selch Larsen High molecular weight prodrug derivatives of antiinflammatory drugs
US5830884A (en) * 1995-01-18 1998-11-03 National Starch And Chemical Investment Holding Corporation Pharmaceutical products containing thermally-inhibited starches
DE10112825A1 (de) 2001-03-16 2002-10-02 Fresenius Kabi De Gmbh HESylierung von Wirkstoffen in wässriger Lösung
DE10209821A1 (de) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung von Proteinen an ein modifiziertes Polysaccharid
DE10209822A1 (de) * 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Kopplung niedermolekularer Substanzen an ein modifiziertes Polysaccharid
EP1400533A1 (en) * 2002-09-11 2004-03-24 Fresenius Kabi Deutschland GmbH HASylated polypeptides, especially HASylated erythropoietin
BR0314107A (pt) * 2002-09-11 2005-07-19 Fresenius Kabi De Gmbh Método de produção de derivados de hidroxialquil amido
AU2003273413A1 (en) 2002-10-08 2004-05-04 Fresenius Kabi Deutschland Gmbh Pharmaceutically active oligosaccharide conjugates
DE10256558A1 (de) * 2002-12-04 2004-09-16 Supramol Parenteral Colloids Gmbh Ester von Polysaccharid Aldonsäuren, Verfahren zu ihrer Herstellung und Verwendung zur Kopplung an pharmazeutische Wirkstoffe
WO2005014655A2 (en) 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
AR048035A1 (es) 2004-03-11 2006-03-22 Fresenius Kabi De Gmbh Conjugados de almidon de hidroxialquilo y una proteina, preparados por aminacion reductora
EP2070950A1 (en) 2007-12-14 2009-06-17 Fresenius Kabi Deutschland GmbH Hydroxyalkyl starch derivatives and process for their preparation
GB0811743D0 (en) 2008-06-26 2008-07-30 Hemosol Biopharma Inc Composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1167794B (de) * 1953-09-03 1964-04-16 Corn Products Company Eine Ges Verfahren zum Einbetten wasserunloeslicher Vitamine und anderer bei der Aufbewahrung sich verschlechternder oder verdampfender Stoffe in eine Umhuellung
US3523938A (en) 1967-12-13 1970-08-11 American Hospital Supply Corp Starch plasma expanders and process of preparation
US3908004A (en) * 1970-05-20 1975-09-23 C L Basingstoke Limited Process for making injectable iron compositions for treating iron-deficiency anemia
US3928581A (en) * 1972-09-13 1975-12-23 Astra Laekemedel Ab Certain polymer-iron complexes for treatment of iron deficiency
DE2500076C3 (de) * 1975-01-02 1982-11-18 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen
US4026986A (en) * 1975-05-22 1977-05-31 The Dow Chemical Company Capsule shell
US4180567A (en) * 1977-09-02 1979-12-25 Pharmachem Corporation Iron preparations and methods of making and administering the same
DE2829037A1 (de) * 1978-07-01 1980-01-10 Fresenius Chem Pharm Ind Wasserloesliche, keimtoetende mittel enthaltende mund- und rachenpflegemittel
DE2838736A1 (de) * 1978-09-06 1980-03-20 Theodor Prof Dr Eckert Verwendung von hydroxyaethylstaerke als pudergrundlage
JPS6348545A (ja) * 1986-08-18 1988-03-01 Nippon Zeon Co Ltd 感光性フレキソ版用エラストマ−組成物

Also Published As

Publication number Publication date
ES491307A0 (es) 1981-05-16
EP0019403A2 (en) 1980-11-26
EP0019403A3 (en) 1981-10-07
KR840001798B1 (ko) 1984-10-20
JPH0140812B2 (zh) 1989-08-31
ATE12892T1 (de) 1985-05-15
EP0028641A4 (en) 1981-09-01
DE3070546D1 (de) 1985-06-05
DK4481A (da) 1981-01-07
WO1980002374A1 (en) 1980-11-13
CA1158159A (en) 1983-12-06
JPS56500495A (zh) 1981-04-16
EP0028641B1 (en) 1985-04-24
ES8105145A1 (es) 1981-05-16
NZ193618A (en) 1984-07-06
DK155078B (da) 1989-02-06
KR830002510A (ko) 1983-05-30
EP0019403B1 (en) 1985-07-31
EP0028641A1 (en) 1981-05-20

Similar Documents

Publication Publication Date Title
DK155078C (da) Fremgangsmaade til fremstilling af en administrationsform med reguleret frigoerelse af en biologisk aktiv forbindelse
DE3486409D1 (de) Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs.
NO163776C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive imidazoquinoksaliner.
IT7824835A0 (it) Derivati dell'acido 1,2,3-tiadiazol-5-carbossilico, mezzi ad azione erbicida e regolatrice della crescita contenenti questi composti eprocedimento per prepararli.
MX9203313A (es) Derivados de quinolina y sus usos para controlar el crecimiento indeseado de plantas.
ATE59967T1 (de) Tierstreu.
ATA768477A (de) Werkzeug zur chirurgischen vorbereitung der implantation eines implantats zur befestigung von festsitzendem zahnersatz
NL7708937A (nl) Werkwijze voor het bereiden van heterocyclische verbindingen, de toepassing ervan voor het be- strijden van dierlijke en plantaardige schade- lijke organismen alsmede voor het regelen van de plantengroei.
DK324385A (da) Farmaceutisk praeparat med kontrolleret frigivelse af det aktive stof
NL7808961A (nl) Preparaten voor het regelen van de groei van planten.
ES545330A0 (es) Un procedimiento para preparar derivados de 1,3-difosfonato
RO82968A (ro) Compozitie de reglare a cresterii plantelor leguminoase
IL54501A (en) N-(trifluoromethanesulphonamidophenyl)-n-heterocyclic compounds,their preparation and their use for regulation of plant growth
IL58446A (en) Substituted 2-(3-pyridinyl)thiazolidin-4-one(and tetrahydro-1,3-thiazin-4-one)derivatives,their preparation and use as plant fungicides and aquatic plant growth regulators
DK445787D0 (da) 2,3,6-substituerede phenylimidazolderivater, fremgangsmaader til deres fremstilling samt deres anvendelse til regulering af plantevaekst
ATA535479A (de) Pflanzenwachstumregelnde und insekticide komposition
DK542687D0 (da) Imidazolderivater, fremgangsmaader til deres fremstilling samt deres anvendelse til regulering af plantevaekst
DK157035C (da) Biologisk ren mikroorganismestamme samt fremgangsmaade til fremstilling af et dyrkningsprodukt heraf til anvendelse som et hudpraeparat
MX170055B (es) , "composicion insecticida y procedimiento para su obtencion
PL211046A1 (pl) Srodek do regulowania wzrostu roslin
DK163980A (da) Fremgangsmaade til fremstilling af et biologisk aktivt stof 41.200rp med immunstimulerende virkning
ES486399A0 (es) Procedimiento para la preparacion de derivados de uretano
DK429082A (da) Fremgangsmaade til fremstilling af et appetitregulerende virksomt stof ud fra humant og/eller animalsk blodserum
DK520079A (da) Substituerede spiroderivater af 3-(3,5-dihalogenphenyl)-oxazolidin-2,4-dioner(-thion/oner) fremgangsmaader til deres fremstilling samt deres anvendelse som fungicider
PL206391A1 (pl) Srodek do regulowania wzrostu roslin